At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,349 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CLINICAL OUTCOME OF ADVANCED RENAL CELL CARCINOMA IN TAIWAN, A RETROSPECTIVE NHIA DATABASE ANALYSIS
In Brief
An observational study for Renal Cell Carcinoma. Completed, enrolled 1,349 participants.
Detailed Summary
The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcome of advanced renal cell carcinoma captured in Taiwan National Health Insurance Research Database.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Cell Carcinoma
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartOct 2016
Primary CompletionDec 2017
TodayJul 2026
First PostedMay 18, 2016
Enrollment StartOct 15, 2016
Primary CompletionDec 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.1 years ago